Friday, July 31, 2026

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Cash Crunch Emerges as Bigger Threat Than Delisting for South Korea’s Listed Biotech Firms

South Korea's biotech firms face cash shortages amid tightening delisting rules, raising concerns over funding and operational viability.

Will the Jones Act Change? Insights from South Korea’s Song Young-gil on U.S.-Korea Shipbuilding Cooperation

Song Young-gil emphasizes the need for U.S. cooperation in shipbuilding and warns of challenges without Jones Act amendments.

Nikola Shares Jump 13% as Investors Bet on a Potential Turnaround

EtcNikola Shares Jump 13% as Investors Bet on a Potential Turnaround
Yahoo Finance
Yahoo Finance

Nikola’s stock remains on a roller coaster ride, surging over 13% despite reports of an impending bankruptcy.

On Monday, Nikola shares jumped 13.16% to 50 cents on the New York Stock Exchange, rebounding from steep losses in recent sessions.

The electric vehicle startup, facing a severe financial crisis, has seen its stock price fluctuate dramatically.

Last Friday, shares plummeted 41% to 44 cents following reports of an imminent bankruptcy filing.

However, the stock surged over 13% that day, likely driven by bargain hunters.

Nikola’s extreme volatility stems from speculative investors betting on a potential turnaround. With shares trading below $1, the downside risk is relatively limited, while a successful recovery could generate substantial gains.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles